Back to Journals » International Journal of Chronic Obstructive Pulmonary Disease » Volume 19

Original Research

Outcomes Following Initiation of Triple Therapy with Fluticasone Furoate/Umeclidinium/Vilanterol versus Multiple-Inhaler Triple Therapy Among Medicare Advantage with Part D Beneficiaries and Those Commercially Enrolled for Health Care Insurance in the United States

       
Total article views   HTML views PDF downloads Totals
1,903 Dovepress* 1,793+ 46 1,839
PubMed Central* 110 78 188
Totals 1,903 124 2,027
*Since 11 January 2024

View citations on PubMed Central and Google Scholar